using surrogate markers of disease progression to improve clinical management of patients with als
Published 11 years ago • 215 plays • Length 18:33Download video MP4
Download video MP3
Similar videos
-
19:28
e-solutions to improve outcomes for people living with als/mnd
-
1:00:04
therapies in als - symptomatic & pre-symptomatic biomarkers for als therapy development
-
6:12
surrogate markers for ms
-
3:23
digital biomarker to #curingals
-
1:27:32
clinical conversations panel
-
55:08
blood metabolites & als - a study of blood metabolites links compounds to risk of als
-
1:29:24
biomarkers in als to aid in earlier diagnosis, clinical trials, and monitor impact of therapies.
-
8:07
als cure is possible - 5 rules i learned to be true
-
16:45
enduring motor neurone disease (mnd \ als) . please, please share
-
1:45:26
als reversals - the 48 documented cases with dr richard bedlack
-
2:13
new marker of als outcome identified
-
3:52
precision medicine program at als tdi
-
1:35:02
speed up als drug discovery by using innovative technology, digital biomarkers, by dr. james berry
-
2:53
biomarkers to accelerate als therapy development
-
1:56
treatments for als (2020)
-
2:53
developing biomarker panels for als diagnosis
-
3:09
target als | understanding the science - spotlight on biomarkers
-
4:27
treatment of excellence for als
-
17:50
"would you do it again?" patient perspective regarding their decision for peg in als
-
12:59
2015 hope through caring gala
-
18:14
reproductive decision-making in familial als